← Leaderboard
INCY
Ticker
INCY
Congressional Trades
12
by 2 members
Buys
7
58%
Sells
5
42%
Total Volume
$96K
midpoint
Unique Traders
2
members
Party Breakdown
Democrats10 · 83%
Republicans2 · 17%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
1▲
Mar '24
—
0▲1▼
Apr '24
—
1▲
Aug '24
—
1▲
Nov '24
—
1▲
Jan '25
—
0▲1▼
Feb '25
—
1▲
May '25⚡
0▲2▼
1▲
Jan '26
—
1▲1▼
Mar '26
—
Democrats7▲3▼Net buyers
vs
Republicans0▲2▼Net sellers
Net buyingNet selling⚡ Party split
🏛️ Federal Contracts
all →- 2026-03-27$500KDepartment of Veterans AffairsPATHOLOGY LAB SERVICES.
💼 Lobbying Filings
all →- 2026-04-20$480KINCYTE CORPORATIONH.R. 946 / S. 1862, Orphan Cures Act implementation H.R. 1262 Give Kids a Chance Act Issues related to Medicaid rebates Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology
- 2026-04-20$60KINCYTE CORPORATIONIssues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC) Issues related to Medicaid rebates; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to CMMI demos (Guarding U.S. Medicare Against Rising Drug Costs (GUARD) and Global Benchmark for Efficient Drug Pricing (GLOBE))
- 2026-04-18$80KINCYTE CORPORATIONIssues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
- 2026-04-18$60KINCYTE CORPORATIONEducation around access to innovative therapies in dermatology. Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.
- 2026-04-17$110KINCYTE CORPORATIONIssues relating to CMS coverage and reimbursement policies.
- 2026-04-17$50KINCYTE CORPORATIONHealthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry.
- 2026-01-20$530KINCYTE CORPORATIONH.R. 946/S. 1862, Orphan Cures Act implementation H.R. 1262 Give Kids a Chance Act Issues related to Medicaid rebates Issues related to Medicaid coverage of new drugs Issues related to implementation of the Inflation Reduction Act Issues related to the 340B Drug Pricing Program Issues related to drug cost and pricing Education around access to innovative therapies in dermatology
- 2026-01-20$80KINCYTE CORPORATIONIssues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
- 2026-01-20$70KINCYTE CORPORATIONIssues relating to CMS coverage and reimbursement policies.
- 2026-01-20$60KINCYTE CORPORATIONEducation around access to innovative therapies in dermatology. Issues related to the 340(b)program. Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act.
Congressional Momentum
buy vs. sell pressureNEUTRALScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
–50
1 buy2 total1 sell
$8K buys · $8K sells
All-Time
▲58
7 buys12 total5 sells
$56K buys · $40K sells
Cumulative Net Position (buy vol − sell vol)
+$16K
2024-0312 trades plotted2026-03
Trade Activity Timeline
Congressional buys & sells by month · last 9 months w/ activity
24/03
24/04
24/08
24/11
25/01
25/02
25/05
26/01
26/03
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade1 buyers ·2 sellers
BuySellOtherDot size ∝ trade size · top 2 most-active traders shown
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay |
|---|---|---|---|---|
| 2026-03-30 | DRo Khanna | BUY | $1K – $15K | 8d |
| 2026-03-10 | DRo Khanna | SELL | $1K – $15K | 28d |
| 2026-01-29 | DRo Khanna | BUY | $1K – $15K | 8d |
| 2025-05-19 | DRo Khanna | BUY | $1K – $15K | 22d |
| 2025-05-15 | RRobert Bresnahan | SELL | $1K – $15K | 18d |
| 2025-05-15 | RRobert Bresnahan | SELL | $1K – $15K | 16d |
| 2025-02-19 | DRo Khanna | SELL | $1K – $15K | 15d |
| 2025-01-17 | DRo Khanna | BUY | $1K – $15K | 20d |
| 2024-11-15 | DRo Khanna | BUY | $1K – $15K | 20d |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d |
| 2024-04-23 | DRo Khanna | SELL | $1K – $15K | 13d |
| 2024-03-25 | DRo Khanna | BUY | $1K – $15K | 11d |